July 2016

SynBioBeta Aims to Fuel Your Passion for Engineering Biology at their 5th Annual San Francisco Conference

Thu, 28/07/2016 - 14:00
San Francisco, CA, USA, 28th July 2016 / Sciad Newswire / SynBioBeta announced today they will again be bringing together the syntheti

Prokarium Receives £2M In Government Contracts to Develop New Vaccines Against Emerging Diseases and Bioterrorist Threats

Mon, 25/07/2016 - 08:00
Prokarium announces funding from UK & Mexican Governments to develop vaccines against Zika, bacterial diarrhoea and Plague.

Biotechnology Veteran Joins Riffyn as Vice President of Product Development and Application Support

Wed, 20/07/2016 - 17:00
Oakland, CA, USA, 19th July 2016 / Sciad Newswire / Riffyn, a developer of cloud-based software for research and development, today announced that Dr.

Cypralis Limited announces agreement with SCYNEXIS Inc. to acquire a large portfolio of cyclophilin inhibitor assets

Wed, 13/07/2016 - 15:00
Cypralis, a life sciences company focussed on the discovery of novel therapeutics based on modulation of peptidyl-prolyl isomerases (PPIases) has acquired a portfolio of cyclophilin inhibitor assets from SCYNEXIS Inc, a NASDAQ-listed company headquartered in New Jersey, USA.

Pearson Medical Technologies and XchangeLabs to Exhibit at RBC Cardinal 2016

Mon, 11/07/2016 - 16:00
 Pearson Medical Technologies, a leader in pharmacy automation solutions, will showcase at RBC Cardinal 2016 in Chicago, IL from July 20-23 with XchangeLabs.

Siemens Investment Accelerates Launch of Riffyn’s Ground-breaking R&D Design Software

Wed, 06/07/2016 - 09:00
Riffyn, Inc. announces an investment by Siemens Venture Capital to accelerate the launch of its cloud-based research process design software.